@misc{indiciae3735a246e624,
  title = {Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19},
  author = {McSweeney, M. D. and Stewart, I. and Richardson, Z. and Kang, H. and Park, Y. and Kim, C. and Tiruthani, K. and Wolf, W. and Schaefer, A. and Kumar, P. and Aurora, H. and Hutchins, J. and Cho, J. M. and Hickey, A. J. and Lee, S. Y. and Lai, S. K.},
  year = {2022},
  doi = {10.1101/2022.02.27.482162},
  url = {https://www.biorxiv.org/content/10.1101/2022.02.27.482162v1},
  note = {Source identifier: 10.1101/2022.02.27.482162}
}